Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15226 - 15250 of 15409 in total

Quifenadine

Experimental

Aluminium clofibrate

Experimental

Penfluridol

Experimental

Xipamide

Experimental

QN-302

Investigational
Matched Iupac: … 6,13-bis[3-(morpholin-4-yl)propyl]-2-{[2-(pyrrolidin-1-yl)ethyl]amino}-9-{4-[(pyrrolidin-1-yl)methyl] …

alpha-Fluoro-carboxymethyldethia coenzyme A complex

Experimental
Matched Iupac: … 9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl …

Morphine glucuronide

Investigational
Matched Iupac: … (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-{[(1S,5R,13R,14S,17R)-10-hydroxy-4-methyl-12-oxa-4-azapentacyclo[ …

Dipipanone

Experimental
Illicit

2,3,4,5,6-Pentafluorobenzyl Alcohol

Experimental

Balanol Analog 2

Experimental

2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide

Experimental

Iodobenzene

Experimental

AL7182

Experimental

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

Experimental

(R)-Bicalutamide

Experimental

PAS219

Experimental

(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester

Experimental

FR239087

Experimental

4-Fluorophenethyl Alcohol

Experimental

Phenacetin

Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn

1,3,5-trichlorobenzene

Experimental

1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea

Experimental

Cannabinor

Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational

Indisulam

Investigational

N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE

Experimental
Displaying drugs 15226 - 15250 of 15409 in total